Cerebrospinal fluid HIV-1 escape in patients with neurocognitive symptoms: pooled data from a neuro-HIV platform and the NAMACO study.

Publication

Cerebrospinal fluid HIV-1 escape in patients with neurocognitive symptoms: pooled data from a neuro-HIV platform and the NAMACO study.

Journal Paper/Review - Mar 15, 2023

Filippidis Paraskevas, Damas José, Viala Benjamin, Assal Frédéric, Tshikung Olivier Nawej, Tarr Philip, Derfuss Tobias, Oberholzer Michael, Jelcic Ilijas, Hundsberger Thomas, Sacco Leonardo, Cavassini Matthias, Du Pasquier Renaud, Darling Katharine E A

Citation

Filippidis P, Damas J, Viala B, Assal F, Tshikung O, Tarr P, Derfuss T, Oberholzer M, Jelcic I, Hundsberger T, Sacco L, Cavassini M, Du Pasquier R, Darling K. Cerebrospinal fluid HIV-1 escape in patients with neurocognitive symptoms: pooled data from a neuro-HIV platform and the NAMACO study. J Acquir Immune Defic Syndr 2023

Type

Journal Paper/Review (English)

Journal

J Acquir Immune Defic Syndr 2023

Publication Date

Mar 15, 2023

Issn Electronic

1944-7884

Brief description/objective

Despite modern antiretroviral therapy, HIV-1 RNA escape into the cerebrospinal fluid (CSF) may occur. We examined the prevalence of and factors associated with CSF HIV-1 escape among people living with HIV (PLWH) in Switzerland.